Steven Cohen (Trades, Portfolio)'s Point72 Asset Management has recently made a notable addition to its investment portfolio by acquiring additional shares in Pulmonx Corp (NASDAQ:LUNG). The firm now holds a 5.00% stake in Pulmonx Corp, representing 0.04% of its investment portfolio. Steven A. Cohen, the Chairman and CEO of Point72 Asset Management, is a prominent figure in the investment world.
Pulmonx Corp (NASDAQ:LUNG), a company specializing in the development and commercialization of minimally invasive treatments for severe lung disease, has reported an insider sell according to a recent SEC filing.